Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Jane

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Journal of Medicinal Chemistry|November 24, 2005
Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptorsNigel P Dolman, Helen M Troop, Julia C A More, et al.
Neuropharmacology|July 17, 2012
The NMDA receptor as a target for cognitive enhancementGraham L Collingridge, Arturas Volianskis, Neil Bannister, et al.
Neuropharmacology|September 16, 2008
ACET is a highly potent and specific kainate receptor antagonist: characterisation and effects on hippocampal mossy fibre functionSheila L Dargan, Vernon R J Clarke, Gregory M Alushin, et al.
Neuropharmacology|May 29, 2004
Characterisation of UBP296: a novel, potent and selective kainate receptor antagonistJulia C A More, Robert Nistico, Nigel P Dolman, et al.
Journal of Medicinal Chemistry|November 25, 2011
Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptorsMark W Irvine, Blaise M Costa, Daniel Dlaboga, et al.
Journal of Medicinal Chemistry|December 3, 2014
Design and nuclear magnetic resonance (NMR) structure determination of the second extracellular immunoglobulin tyrosine kinase A (TrkAIg2) domain construct for binding site elucidation in drug discoveryDebbie K Shoemark, Christopher Williams, Mark S Fahey, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Journal of Medicinal Chemistry|November 24, 2005
Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptorsNigel P Dolman, Helen M Troop, Julia C A More, et al.
Neuropharmacology|July 17, 2012
The NMDA receptor as a target for cognitive enhancementGraham L Collingridge, Arturas Volianskis, Neil Bannister, et al.
Neuropharmacology|September 16, 2008
ACET is a highly potent and specific kainate receptor antagonist: characterisation and effects on hippocampal mossy fibre functionSheila L Dargan, Vernon R J Clarke, Gregory M Alushin, et al.
Neuropharmacology|May 29, 2004
Characterisation of UBP296: a novel, potent and selective kainate receptor antagonistJulia C A More, Robert Nistico, Nigel P Dolman, et al.
Journal of Medicinal Chemistry|November 25, 2011
Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptorsMark W Irvine, Blaise M Costa, Daniel Dlaboga, et al.
Journal of Medicinal Chemistry|December 3, 2014
Design and nuclear magnetic resonance (NMR) structure determination of the second extracellular immunoglobulin tyrosine kinase A (TrkAIg2) domain construct for binding site elucidation in drug discoveryDebbie K Shoemark, Christopher Williams, Mark S Fahey, et al.
Pageof 7